Editorial for the IJMS Special Issue on Sglt2 Inhibitors (Volume 2).

Published in: International journal of molecular sciences (2023)

The goal of the second volume of this Special Issue was to build upon the success of the first one and to continue to highlight the ever-expanding list of pharmacological properties of the sodium/glucose co-transporter (SGLT) type 2 (SGLT2) inhibitor (SGLT2i) drug class (also known as gliflozins) [...].

Keyphrases

adverse drug